NASDAQ:TYME
Delisted

Tyme Technologies Stock Forecast

etoro logo Buy TYME
*Your capital is at risk
$0.311
+0 (+0%)
At Close: Jan 27, 2023

TYME Performance

FAQ

What is the symbol for Tyme Technologies Inc Stock and on which exchange is it traded?
The symbol for Tyme Technologies Inc is TYME and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tyme Technologies Inc Stock?
Tyme Technologies Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Tyme Technologies Inc Stock?
Tyme Technologies Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tyme Technologies Inc Stock.

What's the current price of Tyme Technologies Inc Stock?
As of the end of day on the Jan 27, 2023, the price of an Tyme Technologies Inc (TYME) share was $0.311.

What is the 52-week high and low for Tyme Technologies Inc Stock?
The 52-week high for Tyme Technologies Inc Stock is $0.405 and the 52-week low is $0.219.
Click to get the best stock tips daily for free!
ABOUT TYME TECHNOLOGIES INC
Tyme Technologies
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE